Acute Lymphoblastic Leukemia
Showing NaN - NaN of 58
Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,
Completed
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2021
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Worldwide
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Birmingham, Alabama
- +233 more
Apr 2, 2021
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia Trial in Australia,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Cyclophosphamide
- +12 more
-
Phoenix, Arizona
- +27 more
Apr 2, 2021
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)
Completed
- Leukemia
- Acute Lymphoblastic Leukemia
- Rituximab
- +11 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 1, 2020
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC
Completed
- Acute Myelogenous Leukemia
- +3 more
- Infusion of one MPC expanded cord unit and one unexpanded cord unit
- Infusion of two unexpanded cord blood units.
-
Miami, Florida
- +8 more
Jun 25, 2020
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T
Recruiting
- Non Hodgkin Lymphoma
- +5 more
- TC-110 T Cells
- +2 more
-
Denver, Colorado
- +2 more
Jun 25, 2020
Recurrent Adult Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Houston (BP1001, BP1001
Completed
- Recurrent Adult Acute Myeloid Leukemia
- +3 more
- BP1001
- BP1001 in combination with LDAC
-
Houston, TexasM. D. Anderson Cancer Center
May 26, 2020
Acute Lymphoblastic Leukemia Trial in United States (JCAR015 (CD19-targeted CAR T cells))
Terminated
- Acute Lymphoblastic Leukemia
- JCAR015 (CD19-targeted CAR T cells)
-
Birmingham, Alabama
- +17 more
Apr 30, 2020
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Tetanus
-
Houston, Texas
- +1 more
Apr 20, 2020
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- Asparaginase
- +18 more
-
Birmingham, Alabama
- +133 more
Apr 4, 2020
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in United States (ADCT-301)
Terminated
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
-
Atlanta, Georgia
- +10 more
Feb 12, 2020
Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,
Acute Lymphoblastic Leukemia Trial in Atlanta, Chicago, Houston (Vincristine Sulfate Liposomes Injection, Dexamethasone)
Completed
- Acute Lymphoblastic Leukemia
- Vincristine Sulfate Liposomes Injection
- Dexamethasone
-
Atlanta, Georgia
- +2 more
Dec 10, 2019
Acute Lymphoblastic Leukemia Trial in Houston (CMC-544 (Inotuzumab Ozogamycin), Rituximab)
Completed
- Acute Lymphoblastic Leukemia
- CMC-544 (Inotuzumab Ozogamycin)
- Rituximab
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 21, 2019
Acute Lymphoblastic Leukemia Trial in Worldwide (inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high
Completed
- Acute Lymphoblastic Leukemia
- inotuzumab ozogamicin
- +3 more
-
La Jolla, California
- +197 more
Dec 20, 2018
Leukemia, Lymphoma, Allogeneic Haematopoietic Stem Cell Transplantation Trial in Houston (Busulfan, Clofarabine, Thymoglobulin)
Completed
- Leukemia
- +3 more
- Busulfan
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 11, 2018
Acute Lymphoblastic Leukemia Trial in Columbus, Memphis, Houston (MOR00208 (formerly Xmab5574))
Terminated
- Acute Lymphoblastic Leukemia
- MOR00208 (formerly Xmab5574)
-
Columbus, Ohio
- +2 more
Feb 20, 2018
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,
Completed
- Acute Lymphoblastic Leukemia
- +4 more
- ABT-348
- ABT-348 and azacitidine
-
Scottsdale, Arizona
- +2 more
Nov 16, 2017
Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
-
Duarte, California
- +38 more
Jul 18, 2017
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in United States (pegcrisantaspase)
Terminated
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
-
Phoenix, Arizona
- +42 more
Mar 6, 2017
Acute Lymphoblastic Leukemia Trial in Worldwide (Blinatumomab)
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
-
Aurora, Colorado
- +29 more
Dec 16, 2016
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)
Terminated
- Acute Myelogenous Leukemia
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 16, 2016